Goldman Sachs NYSERamin Talaie/ Corbis/ Getty Images

Hedge fund outlook in healthcare stocks reached a record 10 percentage points overweight compared to the Russell 3000 index, Goldman Sachs said Friday. The spin was primarily fueled by soaring interest in biotech calls. Recent weeks have seen investors pile into corporations racing to introduce the first coronavirus treatment. Positioning has moved forward more crowded both within and across funds in the second quarter, Goldman added, as managers revolve so far toward proliferation inventories and defensive plays. Visit the Business Insider homepage for more narratives.

Hedge funds are reaching record levels of exposure to healthcare stocks as the coronavirus pandemic furies on, Goldman Sachs said Friday.

The sector sits 10 percentage points overweight across hedge funds compared to the Russell 3000 sector, the bank added, stimulating it “the worlds largest” favored industry among managers. Funds monitored by Goldman are nearly 25% concentrated in healthcare equities, with tech corporations following with a 20% weighting.See the rest of the tale at Business Insider

NOW WATCH: Pathologists debunk 13 coronavirus stories

See Also 😛 TAGENDThese 11 stocks desired by hedge funds have beaten world markets during both the coronavirus breakdown and its subsequent convalescence, RBC saysThe investment chief of a $12 billion wealth-management firm breaks down how to build the perfect portfolio applying merely 7 ETFs — one designed to sidestep a dramatically ‘overvalued’ stock exchangeA BlackRock money manager overseeing the top healthcare fund of the past 20 times pinpoints 3 proliferation regions she’s potting on — and one she’s avoiding amid the coronavirus convalescence

Read more: